- Global Pharma News & Resources

Press Releases - 2019-02-12

Date Title Company
12-Feb-2019 MIT Releases New Policy and Practice Suggestions to Make Cures Accessible and Sustainable MIT Center for Biomedical Innovation
12-Feb-2019 Harmony Biosciences Announces File Acceptance Of Its New Drug Application For Pitolisant Harmony Biosciences, LLC
12-Feb-2019 FDA Advisory Committee Recommends Approval of SPRAVATO(TM) (esketamine) Nasal Spray CIII for Adults with Treatment-Resistant Depression Janssen Pharmaceutical Companies of Johnson & Johnson
12-Feb-2019 Jazz Pharmaceuticals to Report 2018 Fourth Quarter and Full Year Financial Results on February 26, 2019 Jazz Pharmaceuticals plc
12-Feb-2019 Addiction Medicine Practice Opens its 1st Opioid and Alcohol Treatment Center in Northern VA SaVida Health
12-Feb-2019 Novus Detox Medical Director to Speak at Southeastern U.S. Regional Drug Prevention Summit Novus Medical Detox Centers
12-Feb-2019 Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer Skyhawk Therapeutics
12-Feb-2019 Hansa Biopharma appoints Donato Spota as new Chief Financial Officer Hansa Biopharma
12-Feb-2019 Frost & Sullivan Publishes Immediate Report on BiolineRx Frost & Sullivan
12-Feb-2019 Award-Winning, FDA-Cleared Technology Uses Body's Own Fat to Help Heal Orthopedic Injuries Lipogems
12-Feb-2019 Medisafe launches new program, Mediscoveries, providing unique insight into medication management performance Medisafe
12-Feb-2019 Taylor Publishing Announces The Availability Of New Book "Warrior CEO" Mark Taylor
12-Feb-2019 Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic U.S. Food and Drug Administration
12-Feb-2019 Mylan Launches Wixela(TM) Inhub(TM) (fluticasone propionate and salmeterol inhalation powder, USP), the First Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder), at a List Price 70% Less than the Brand Mylan N.V.
12-Feb-2019 Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2 Neurotech Pharmaceuticals, Inc.
12-Feb-2019 Breckenridge Announces Tetracycline Capsules Launch Breckenridge Pharmaceutical, Inc.
12-Feb-2019 Pulmatrix Receives Five Patents Supporting Claims for their Novel Inhaled Narrow Spectrum Kinase Inhibitor Programs Pulmatrix, Inc.
12-Feb-2019 GS1 Delivers New Lightweight Messaging Standard for Verification of Product Identifiers GS1
12-Feb-2019 Cannabis Makes Medical Inroads as Opioid Epidemic Continues
12-Feb-2019 GC Pharma Reports Full Year 2018 Results GC Pharma